Search Results

There are 5488 results for: content related to: Clinical development of novel therapeutics for castration-resistant prostate cancer

  1. You have free access to this content
    Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 3, August 2012, Pages: 328–335, A. Oliver Sartor and John M. Fitzpatrick

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1464-410X.2011.10818.x

  2. You have free access to this content
    Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 658–667, Heather Payne, Amit Bahl, Malcolm Mason, Janis Troup and Johann De Bono

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1464-410X.2011.10886.x

  3. You have free access to this content
    Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?

    BJU International

    Volume 115, Issue 3, March 2015, Pages: 364–372, Nicolas Mottet, Noel Clarke, Maria De Santis, Filiberto Zattoni, Juan Morote and Steven Joniau

    Version of Record online : 15 JUL 2014, DOI: 10.1111/bju.12736

  4. Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone

    The Prostate

    Volume 75, Issue 12, September 1, 2015, Pages: 1329–1338, Vincenza Conteduca, Orazio Caffo, Lisa Derosa, Antonello Veccia, Elisabetta Petracci, Vincenzo Emanuele Chiuri, Matteo Santoni, Daniele Santini, Lucia Fratino, Francesca Maines, Sara Testoni and Ugo De Giorgi

    Version of Record online : 15 MAY 2015, DOI: 10.1002/pros.23014

  5. You have free access to this content
    Quo vadis: Advanced prostate cancer—clinical care and clinical research in the era of multiple androgen receptor-directed therapies

    Cancer

    Volume 121, Issue 3, February 1, 2015, Pages: 361–371, Won Kim and Charles J. Ryan

    Version of Record online : 18 SEP 2014, DOI: 10.1002/cncr.28929

  6. You have free access to this content
    New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  7. You have free access to this content
    Multidisciplinary consensus: A practical guide for the integration of abiraterone into clinical practice

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 3, September 2014, Pages: 228–236, Henry H Woo, Stephen Begbie, Kumar Gogna, Paul N Mainwaring, Declan G Murphy, Francis Parnis, Christopher Steer and Ian D Davis

    Version of Record online : 17 AUG 2014, DOI: 10.1111/ajco.12264

  8. You have free access to this content
    Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 109, Issue 7, April 2012, Pages: 968–985, Daniel J. Lee, Eugene K. Cha, Justin M. Dubin, Himisha Beltran, Thomas F. Chromecki, Harun Fajkovic, Douglas S. Scherr, Scott T. Tagawa and Shahrokh F. Shariat

    Version of Record online : 28 OCT 2011, DOI: 10.1111/j.1464-410X.2011.10643.x

  9. You have free access to this content
    Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)

    BJU International

    Volume 116, Issue 1, July 2015, Pages: 17–29, Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh and Andrew J. Armstrong

    Version of Record online : 23 OCT 2014, DOI: 10.1111/bju.12867

  10. You have free access to this content
    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2583–2593, Jorge A. Garcia and Brian I. Rini

    Version of Record online : 28 OCT 2011, DOI: 10.1002/cncr.26582

  11. You have free access to this content
    CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: E760–E772, Michel D. Wissing, Jules L.L.M. Coenen, Pieter van den Berg, Hans M. Westgeest, Alfons J.M. van den Eertwegh, Inge M. van Oort, Monique M. Bos, André M. Bergman, Paul Hamberg, Albert J. ten Tije, Maartje Los, Martijn P.J.K. Lolkema, Ronald de Wit and Hans Gelderblom

    Version of Record online : 3 OCT 2014, DOI: 10.1002/ijc.29231

  12. Androgen receptor targeting drugs in castration-resistant prostate cancer and mechanisms of resistance

    Clinical Pharmacology & Therapeutics

    Volume 98, Issue 6, December 2015, Pages: 582–589, DJ Crona, MI Milowsky and YE Whang

    Version of Record online : 1 OCT 2015, DOI: 10.1002/cpt.256

  13. Development and Clinical Utility of Abiraterone Acetate as an Androgen Synthesis Inhibitor

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 1, January 2012, Pages: 101–108, A Bryce and C J Ryan

    Version of Record online : 30 NOV 2011, DOI: 10.1038/clpt.2011.275

  14. You have full text access to this OnlineOpen article
    Targeting the adaptive molecular landscape of castration-resistant prostate cancer

    EMBO Molecular Medicine

    Volume 7, Issue 7, July 2015, Pages: 878–894, Alexander W Wyatt and Martin E Gleave

    Version of Record online : 20 APR 2015, DOI: 10.15252/emmm.201303701

  15. You have full text access to this OnlineOpen article
    Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer

    BJU International

    Volume 117, Issue 2, February 2016, Pages: 215–225, Jack Schalken and John M. Fitzpatrick

    Version of Record online : 6 JUN 2015, DOI: 10.1111/bju.13123

  16. You have free access to this content
    Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 110, Issue 11, December 2012, Pages: 1580–1588, Che-Kai Tsao, Matthew D. Galsky, Alexander C. Small, Tiffany Yee and William K. Oh

    Version of Record online : 18 SEP 2012, DOI: 10.1111/j.1464-410X.2012.11445.x

  17. Targeted therapy in prostate cancer

    Histopathology

    Volume 60, Issue 1, January 2012, Pages: 216–231, Niall M Corcoran and Martin E Gleave

    Version of Record online : 23 DEC 2011, DOI: 10.1111/j.1365-2559.2011.04030.x

  18. You have free access to this content
    Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 3, September 2014, Pages: 205–215, Phillip Parente, Francis Parnis and Howard Gurney

    Version of Record online : 3 APR 2014, DOI: 10.1111/ajco.12193

  19. You have full text access to this OnlineOpen article
    Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic

    International Journal of Urology

    Volume 23, Issue 8, August 2016, Pages: 654–665, Yusuke Imamura and Marianne D Sadar

    Version of Record online : 14 JUN 2016, DOI: 10.1111/iju.13137

  20. You have free access to this content
    Current and emerging treatment modalities for metastatic castration-resistant prostate cancer

    BJU International

    Volume 107, Issue s2, April 2011, Pages: 13–20, Sergio Bracarda, Christopher Logothetis, Cora N. Sternberg and Stéphane Oudard

    Version of Record online : 7 MAR 2011, DOI: 10.1111/j.1464-410X.2010.10036.x